top of page
a paradigm shifting proteomics platform

redalpine

biognosys

biognosys is a proteomics company specializing in mass spectrometry-based solutions for precise protein quantification and biomarker discovery. its paradigm shifting platform enables the comprehensive analysis of complex biological samples, aiding researchers in understanding cellular processes and diseases. biognosys' patented tools accelerate the drug development process, providing better diagnosis, and allowing patient specific treatment schemes.

precise biomarker discovery for better diagnosis

rac IV
biotech
2009
2008
fund
sector
invested in
founded

ceo oliver rinner

Another successful exit for Redalpine

Jan 12, 2016

related stories

bottom of page